Stiemazol Cream 1 % is primarily indicated in conditions like Advanced breast or prostate cancer, Erythrasma, Leishmaniasis, Mucocutaneous candidiasis, Oropharangeal candidiasis, Orophyrangeal candidiasis, Tinea corporis, Tinea cruris, Tinea pedis, Tinea versicolor, Trichomonal vaginitis, Vaginitis, Yeast infection, and can also be given in adjunctive therapy as an alternative drug of choice in Dermatophytic infections.
Stiemazol Cream 1 % is contraindicated in conditions like Hypersensitivity.
The symptomatic adverse reactions produced by Stiemazol Cream 1 % are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Diarrhea, Abdominal cramps, Pruritus, Sedation, Burning, Hallucination, Depression, Polyuria, Skin irritation, Disorientation, Contact dermatitis, Elevated serum llipids, Elevated alkaline phosphatase, Elevated hepatic transaminases, Vaginal irritation, GI irritation, Vision disturbances, Chemical cystitis, Hypersensitivity rash, urethral irritation.
Stiemazol Cream 1 % should be used cautiously during pregnancy. It should be used with caution in patients with medical history or allergies. Self-administration of Stiemazol Cream 1 % for longer than 7 days is contraindicated. If there is no improvement in the condition after 3 days, or if the condition persists after 7 days, patient should discontinue the Stiemazol Cream 1 % therapy and consult a physician. Topical application of Stiemazol Cream 1 % is contraindicated in the children under the age of 2, unless recommended by the physician.